Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 10,050
-100 (-0.99%)
Jul 18, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 233.74 billion as of July 18, 2025. Its market cap has decreased by -36.35% in one year.
Market Cap
233.74B
Enterprise Value
195.69B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10,050.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 233.74B, an increase of 45.87%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 233.74B | -2.54% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 423.85T |
| SK hynix | 204.34T |
| Samsung Biologics | 73.52T |
| LG Energy Solution | 72.77T |
| Hyundai Motor Company | 45.35T |
| KB Financial Group | 41.37T |
| Doosan Enerbility | 40.73T |
| Hanwha Aerospace | 40.29T |